Key senators make a big pivot on bipartisan insulin cost proposal
WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate,…
Author: STAT
Opinion: I’m a medical resident. I want to pause the drive to unionize hospital trainees
Medicine is a calling. But far too often, trainees — residents and fellows — at…
Opinion: I’m a medical resident. Here’s why I think my hospital should unionize
As a third-year neurology resident at Mass General Brigham, I started my career at the…
Tired of ‘dead end’ approach, herpes patients mobilize to demand government action
A medical student spoke emotionally about grappling with a diagnosis his classes told him little…
STAT+: FTC countersues HCA, Louisiana hospital system to stop acquisitions
The Federal Trade Commission on Thursday sued two hospital systems, HCA Healthcare and LCMC Health,…
Suspected suicide attempts surged among youth during pandemic, study shows
The rate of suspected suicide attempts by self-poisoning among children and adults aged 10 to…
Listen: Sarepta’s pivotal moment, biotech’s big week, & the future of Covid boosters
How can you be sure a gene therapy is working? What does $11 billion get…
STAT+: HCA, Louisiana hospital system sue FTC over review of hospital deal
HCA Healthcare and LCMC Health each sued the Federal Trade Commission and Department of Justice…
Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Narcan manufacturer aims to price over-the-counter kit under $50
The manufacturer of Narcan, the overdose reversal medication that received over-the-counter status last month, says…
Biden to tap head of National Cancer Institute to lead NIH
President Biden will nominate oncologist Monica Bertagnolli, director of the National Cancer Institute, to lead…
STAT+: Powerful Senate duo drops a bipartisan PBM reform plan
WASHINGTON — The chair and ranking Republican on the Senate Finance Committee on Thursday unveiled…
STAT+: Pharmalittle: White House to tap cancer center chief to lead NIH; generic abortion pill maker sues FDA
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: The high hopes — and high stakes — behind Microsoft and Epic’s plan to use AI to answer patient questions
Generative artificial intelligence tools have triggered a flood of speculation about the technology’s ability to…
STAT+: Stock drama, cancer vaccine success, and new science – highlights from AACR
ORLANDO, Fla. – There was some drama at the American Association for Cancer Research annual…
Opinion: Judicial overreach is an immediate hazard to already precarious public health
The United States is in poor health. Life expectancy rates have dropped precipitously, and racial…
The NIH has poured $1 billion into long Covid research — with little to show for it
WASHINGTON — The federal government has burned through more than $1 billion to study long…
Opinion: Generative AI’s three possibly insurmountable challenges for health care
Talk about AI in medicine often focuses on the most exiting possible innovations like precision…
Study: Black women should start breast cancer screening at age 42
For many years, there’s been considerable debate about the best age for women to initiate…
STAT+: Congress targets reducing hospital outpatient payments in new bills
WASHINGTON — House Republicans are floating several draft bills that would significantly affect the hospital…
FDA’s new plan to study opioids’ effectiveness faces resistance
The Food and Drug Administration’s latest plan to study whether opioids are effective as a…
STAT+: FDA’s Califf talks cell and gene therapies, abortion pill, Alzheimer’s drugs
WASHINGTON — Senators grilled FDA Commissioner Rob Califf Wednesday on everything from the agency’s stance…
STAT+: Senate still hasn’t made hard decisions on lowering insulin costs
WASHINGTON — Senate Democrats are trying to cap insulin costs for every American, but they…
Supreme Court delays ruling on abortion pill restrictions
The U.S. Supreme Court on Wednesday extended a stay on limits to a federally approved…
CDC advisory panel backs changes to Covid vaccination policy
An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy…
STAT+: PhRMA execs paint grim picture of industry under Medicare drug price negotiation
WASHINGTON — Executives for the brand drug industry’s biggest lobbying group painted a grim picture…
STAT+: Amazon strikes partnership with 3M to advance conversational AI in medicine
Health care companies are joining forces with big tech players as they race to integrate…
STAT+: STAT-Harris Poll: Most Americans are worried about RSV
A majority of Americans are concerned about the health threat posed by the respiratory syncytial…
STAT+: Pharmalittle: GSK manufacturing workers in the U.K. to strike in May; weight-loss drugs prompt strange dreams
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Relay’s breast cancer drug proves tolerable, but market is unimpressed
ORLANDO, Fla. — Researchers presented early phase trial results on RLY-2608, Relay Therapeutics’ next-generation PI3K…
STAT+: Leaked study results show a CAR-T from J&J providing big benefit for patients with multiple myeloma
The CAR-T cancer therapy called Carvykti, made by Johnson & Johnson and Legend Biotech, reduced…
Discrimination lawsuit against HHMI spotlights barriers faced by scientists with disabilities
University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic…
STAT+: Mindpath seemed like a success story for private equity in mental health. Now, it’s a cautionary tale
As a Covid-driven mental health crisis enveloped the U.S. in 2020, two private equity firms…
Opinion: RSV vaccine approval should be a top priority for the FDA
The calamity of March 2020 arrived two years later for pediatric units. In the fall…
Opinion: The window is closing to stop deadly drug-resistant fungi like Candida auris
Just one week after the season finale of the HBO show “The Last of Us,”…
STAT+: Mark Cuban’s drug company creates a pharmacy network to challenge PBMs
In its latest bid to upend the pharmaceutical supply chain, the Mark Cuban Cost Plus…
STAT+: Novel strategy of attacking sugars on cancer cells to free immune system shows promise in early tests
ORLANDO, Fla. — Many cancer cells shroud themselves in a thicket of complex sugars called…
FDA says older adults and the immunocompromised may get a spring booster dose of Covid vaccine
People aged 65 and older and those who are immunocompromised will be allowed to receive…
STAT+: Pharmalittle: GSK will buy Bellus Health for $2 billion; FDA inspectors are leaving faster than they can be replaced
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Define Ventures raises $460 million to fuel early-stage health tech startups
At a challenging time for digital health startups, Define Ventures announced on Tuesday it has…
In a town plagued by an environmental crisis, a local abortion debate consumes public attention
BRISTOL, Tenn. — Zoe Poplin cupped her hands around her 17-month-old’s head, as if her…
Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health
Over the past five years, digital mental health has risen from a niche topic to…
Opinion: Rural hospitals are closing labor and delivery services. Babies’ lives are in jeopardy
A hospital in Idaho recently announced it will shutter its labor and delivery services due…
STAT+: GSK to buy Bellus Health for $2 billion, gaining chronic cough drug
LONDON — GSK said Tuesday it would purchase Bellus Health for $2 billion, adding a…
STAT+: Most large U.S. funders of clinical research have poor transparency policies, analysis finds
Amid ongoing concern over clinical trial transparency, a new analysis finds that only 37% of…
STAT+: Why do some blood stem cells go rogue? Study offers clue and possible target
ORLANDO, Fla. – Long before leukemia forms, patients often have a population of blood or…
STAT+: Pharmalittle: Merck to acquire Prometheus Biosciences for $10.8 billion; mRNA cancer vaccine reduces melanoma relapse
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Q&A: What does it mean when a clinical trial is delayed? More than you think
Frank David was just starting an independent research program on cell signaling in cancer and…
Free Uber rides helped patients keep their prenatal appointments. Now the company wants insurers to pay for it
For patients of the Community of Hope and Mary’s Center clinics in Washington, D.C., getting…
Opinion: OTC naloxone is a baby step toward making the life-saving medication accessible
In an attempt to make naloxone more accessible amid the massive human toll of the…